Empagliflozin, an SGLT2 inhibitor, is proven safe and effective for heart attack patients, offering a new treatment option to improve outcomes.

At least two government departments are embracing the future by using artificial intelligence to improve efficiencies and deliver best outcomes.

The rapid shift to renewables carries significant risks to already stressed ecosystems. Our research finds ways to minimise this risk, ranging from...

The rapid shift to renewables carries significant risks to already stressed ecosystems. Our research finds ways to minimise this risk, ranging from...

The power of using AI in the Cloud within Research and Education is only starting to be understood with the ability to manage and understand complex...

Researchers at Wake Forest University School of Medicine have made an important discovery that connects high sugar intake to Alzheimer’s disease, a...

Ehrapy is an open-source tool enabling hypothesis-free analysis of complex health data, unlocking new insights and improving research applications...

Ehrapy is an open-source tool enabling hypothesis-free analysis of complex health data, unlocking new insights and improving research applications...

Researchers at Tokyo Medical and Dental University have found that the periodontal bacterium Aggregatibacter actinomycetemcomitans exacerbates...

New research shows that around 14% of children and teens in the U.S. either have high blood pressure or are close to developing it. This highlights...